Literature DB >> 22914734

A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions.

Francisca Diaz1, Sofia Garcia, Kyle R Padgett, Carlos T Moraes.   

Abstract

We have created two neuron-specific mouse models of mitochondrial electron transport chain deficiencies involving defects in complex III (CIII) or complex IV (CIV). These conditional knockouts (cKOs) were created by ablation of the genes coding for the Rieske iron-sulfur protein (RISP) and COX10, respectively. RISP is one of the catalytic subunits of CIII and COX10 is an assembly factor indispensable for the maturation of Cox1, one of the catalytic subunits of CIV. Although the rates of gene deletion, protein loss and complex dysfunction were similar, the RISP cKO survived 3.5 months of age, whereas the COX10 cKO survived for 10-12 months. The RISP cKO had a sudden death, with minimal behavioral changes. In contrast, the COX10 cKO showed a distinctive behavioral phenotype with onset at 4 months of age followed by a slower but progressive neurodegeneration. Curiously, the piriform and somatosensory cortices were more vulnerable to the CIII defect whereas cingulate cortex and to a less extent piriform cortex were affected preferentially by the CIV defect. In addition, the CIII model showed severe and early reactive oxygen species damage, a feature not observed until very late in the pathology of the CIV model. These findings illustrate how specific respiratory chain defects have distinct molecular mechanisms, leading to distinct pathologies, akin to the clinical heterogeneity observed in patients with mitochondrial diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914734      PMCID: PMC3490513          DOI: 10.1093/hmg/dds350

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome.

Authors:  Albert Quintana; Shane E Kruse; Raj P Kapur; Elisenda Sanz; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Quantitative MRI analysis of brain volume changes due to controlled cortical impact.

Authors:  Niall C Colgan; Michelle M Cronin; Oliviero L Gobbo; Shane M O'Mara; William T O'Connor; Michael D Gilchrist
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

Review 3.  Emerging therapeutic approaches to mitochondrial diseases.

Authors:  Tina Wenz; Sion L Williams; Sandra R Bacman; Carlos T Moraes
Journal:  Dev Disabil Res Rev       Date:  2010

Review 4.  Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.

Authors:  Jorge M A Oliveira
Journal:  J Neurochem       Date:  2010-04-09       Impact factor: 5.372

Review 5.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

Review 6.  Mitochondrial generation of free radicals and hypoxic signaling.

Authors:  Robert O Poyton; Kerri A Ball; Pablo R Castello
Journal:  Trends Endocrinol Metab       Date:  2009-09-03       Impact factor: 12.015

Review 7.  Respiratory-chain diseases related to complex III deficiency.

Authors:  Paule Bénit; Sophie Lebon; Pierre Rustin
Journal:  Biochim Biophys Acta       Date:  2008-06-13

Review 8.  Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade.

Authors:  Douglas S Kerr
Journal:  Mol Genet Metab       Date:  2009-11-26       Impact factor: 4.797

Review 9.  The sites and topology of mitochondrial superoxide production.

Authors:  Martin D Brand
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

10.  Evaluation of the mitochondrial respiratory chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays.

Authors:  Antoni Barrientos; Flavia Fontanesi; Francisca Díaz
Journal:  Curr Protoc Hum Genet       Date:  2009-10
View more
  39 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

2.  MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.

Authors:  Masami Hashimoto; Sandra R Bacman; Susana Peralta; Marni J Falk; Anne Chomyn; David C Chan; Sion L Williams; Carlos T Moraes
Journal:  Mol Ther       Date:  2015-07-10       Impact factor: 11.454

3.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

4.  Coenzyme q and the respiratory chain: coenzyme q pool and mitochondrial supercomplexes.

Authors:  José Antonio Enriquez; Giorgio Lenaz
Journal:  Mol Syndromol       Date:  2014-07

5.  Deletion of the Mitochondrial Complex-IV Cofactor Heme A:Farnesyltransferase Causes Focal Segmental Glomerulosclerosis and Interferon Response.

Authors:  Jea-Hyun Baek; Ivan G Gomez; Yukihiro Wada; Allie Roach; Don Mahad; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2018-09-28       Impact factor: 4.307

6.  Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis.

Authors:  Ying Wang; Daniella Oxer; Siegfried Hekimi
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

Review 7.  Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease.

Authors:  Nadee Nissanka; Carlos T Moraes
Journal:  FEBS Lett       Date:  2018-01-09       Impact factor: 4.124

Review 8.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

9.  Novel TTC19 mutation in a family with severe psychiatric manifestations and complex III deficiency.

Authors:  Célia Nogueira; José Barros; Maria José Sá; Luísa Azevedo; Ricardo Taipa; Alessandra Torraco; Maria Chiara Meschini; Daniela Verrigni; Claudia Nesti; Teresa Rizza; João Teixeira; Rosalba Carrozzo; Manuel Melo Pires; Laura Vilarinho; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2013-03-28       Impact factor: 2.660

10.  Cre recombinase activity is inhibited in vivo but not ex vivo by a mutation in the asymmetric spacer region of the distal loxP site.

Authors:  Tania Arguello; Carlos T Moraes
Journal:  Genesis       Date:  2015-09-18       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.